Avadel Pharma Earnings beat, Revenue Inline In Q1

  • Investing.com
Avadel Pharma Earnings beat, Revenue Inline In Q1

Investing.com - Avadel Pharma reported first quarter earnings that beat analysts' expectations on Monday and revenue that was inline with forecasts.

The firm reported earnings per share of $-0.23 on revenue of $0.00. Analysts polled by Investing.com forecast EPS of $-0.3057 on revenue of $0.00. .

For the year, Avadel Pharma shares are up 53.73%, outperforming the S&P 500 which is up 11.53% year to date.

Avadel Pharma follows other major Healthcare sector earnings this month


On Tuesday, April 20, 2021, J&J reported first quarter EPS of $2.59 on revenue of $22.32B, compared to forecasts of EPS of $2.34 on revenue of $21.98B.

Pfizer earnings beat analyst's expectations on Tuesday, May 4, 2021, with first quarter EPS of $0.93 on revenue of $14.58B. Investing.com analysts expected EPS of $0.7759 on revenue of $13.65B

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100